Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
Woody G, Bruce D, Korthuis PT, Chhatre S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Poole S, Metzger D, Ling W. Woody G, et al. Among authors: korthuis pt. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):e142-3. doi: 10.1097/QAI.0000000000000344. J Acquir Immune Defic Syndr. 2014. PMID: 25243431 Free PMC article. No abstract available.
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study.
Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R; BHIVES Collaborative. Altice FL, et al. Among authors: korthuis pt. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S22-32. doi: 10.1097/QAI.0b013e318209751e. J Acquir Immune Defic Syndr. 2011. PMID: 21317590 Free PMC article. Clinical Trial.
The cost of integrated HIV care and buprenorphine/naloxone treatment: results of a cross-site evaluation.
Schackman BR, Leff JA, Botsko M, Fiellin DA, Altice FL, Korthuis PT, Sohler N, Weiss L, Egan JE, Netherland J, Gass J, Finkelstein R; BHIVES Collaborative. Schackman BR, et al. Among authors: korthuis pt. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S76-82. doi: 10.1097/QAI.0b013e31820a9a66. J Acquir Immune Defic Syndr. 2011. PMID: 21317599 Free PMC article.
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine.
Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D; BHIVES Collaborative. Korthuis PT, et al. J Acquir Immune Defic Syndr. 2011 Mar 1;56 Suppl 1(Suppl 1):S83-90. doi: 10.1097/QAI.0b013e31820bc9a5. J Acquir Immune Defic Syndr. 2011. PMID: 21317600 Free PMC article.
NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.
Tross S, Campbell AN, Calsyn DA, Metsch LR, Sorensen JL, Shoptaw S, Haynes L, Woody GE, Malow RM, Brown LS Jr, Feaster DJ, Booth RE, Mandler RN, Masson C, Holmes BW, Colfax G, Brooks AJ, Hien DA, Schackman BR, Korthuis PT, Miele GM; Clinical Trials Network HIV Special Interest Group. Tross S, et al. Among authors: korthuis pt. Am J Drug Alcohol Abuse. 2011 Sep;37(5):283-93. doi: 10.3109/00952990.2011.596977. Am J Drug Alcohol Abuse. 2011. PMID: 21854270 Free PMC article.
Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care.
Korthuis PT, Fiellin DA, McGinnis KA, Skanderson M, Justice AC, Gordon AJ, Doebler DA, Asch SM, Fiellin LE, Bryant K, Gibert CL, Crystal S, Goetz MB, Rimland D, Rodriguez-Barradas MC, Kraemer KL. Korthuis PT, et al. J Acquir Immune Defic Syndr. 2012 Oct 1;61(2):171-8. doi: 10.1097/QAI.0b013e31826741aa. J Acquir Immune Defic Syndr. 2012. PMID: 22820808 Free PMC article.
234 results